News

Jackie Manthorne Recognised with Jack Shapiro Lifetime Achievement Award

Ottawa, ON – Jackie Manthorne, President and CEO of the Canadian Cancer Survivor Network (CCSN), has spent over twenty years giving a voice to cancer patients, survivors and caregivers. This fall, that dedication was recognised by the Canadian Cancer Action Network (CCAN), which awarded Manthorne the 2017 Jack Shapiro Lifetime Achievement Award at their Annual

Read More

Watch: Webinar on biosimilars

Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and help to drive prices down through competition, but doctors, patients and caregivers need to understand what biosimilars are, what they can do, and

Read More

Register now for our free webinar on biosimilars

Title What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada Time Thursday, October 19 1:00pm – 2:00pm EST REGISTER NOW Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and

Read More

Watch our webinar titled “Cancer Associated Blood Clots”

This webinar introduces you to the effects of blood clots on cancer patients. This webinar also provides you with the following information: How and why blood clots effect cancer patients more than the general population Diagnosis and treatment options Resources for more information The presentation is followed by an interactive discussion with participants. Presenter Information Dr.

Read More

Avelumab Survey

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of Avelumab for the treatment of patients with Merkel cell carcinoma. The survey will be open until Oct. 20. The results of our survey are to be submitted in our patient evidence study to the

Read More

Register now for our upcoming webinar on cancer-associated blood clots

Don’t miss the Canadian Cancer Survivor Network’s next webinar on cancer-associated blood clots! Every year there are 30,000 incidences of cancer-associated thrombosis (CAT) in Canada, with approximately 20 to 25 percent of the more than 200,000 Canadians diagnosed with cancer developing blood clots at some point during their cancer treatment. For patients already dealing with

Read More